Table 3.

Insoluble Aβ40 and Aβ42 levels in temporal and occipital cortices of the core Alzheimer’s disease and nondemented control cases, as measured by ELISA. Aβ levels are presented relative to wet tissue weight (fmol Aβ/100μg wet weight tissue).

Group	Case	Temporal Cortex			Occipital Cortex
		Aβ40	Aβ42	Total Aβ	Aβ40	Aβ42	Total Aβ
Alzheimer’s	AD1	1126.13	790.51	1916.63	2685.25	912.84	3598.09
	AD2	39.84	174.88	214.72	15.49	297.96	313.45
	AD3	62.48	97.56	160.04	5.23	186.51	191.73
	AD4	17.75	196.38	214.13	10.29	191.29	201.58
	AD5	275.37	352.57	627.94	n/a	n/a	n/a
	AD6	3.88	444.72	448.59	n/a	n/a	n/a
	AD7	7.65	217.09	224.74	10.97	176.23	187.21
	AD8	4.07	155.58	159.66	n/a	n/a	n/a
	AD9	0.62	145.53	146.15	0.21	59.36	59.57
	AD10	3.37	82.91	86.28	2.18	211.23	213.41
	AD means:	154.12	265.77	419.89	389.95	290.77	680.72
Nondemented	ND1	0	0	0	0.19	0.22	0.41
	ND2	0	0.98	0.98	0.23	1.27	1.50
	ND3	0.03	0.23	0.26	0	0.62	0.62
	ND means:	0.01	0.40	0.41	0.14	0.70	0.84